特拉维尔治疗 TVTX
$49.60 +$0.73 (+1.49%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $49.00 -1.21%
开盘$49.74
昨收$48.87
当日区间$48.64 – $50.45
成交量1.01M
市值$4.76B
市盈率（TTM）–
股息率–
TVTX 相关新闻
匹配 Travere Therapeutic 或代码 TVTX 的头条新闻，按最新排序。
- Guggenheim Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Raises Target Price to $89 正面
- BofA Securities Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Maintains Target Price $71
- Wedbush Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Raises Target Price to $76 正面
- Travere Therapeutics: Eric Dube, Ph.D., to Step Down as Pres and CEO in Dec TVTX
- A Quick Look at Today's Ratings for Travere Therapeutic(TVTX.US), With a Forecast Between $70 to $90
- J.P. Morgan Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Raises Target Price to $90 正面
- A Quick Look at Today's Ratings for Travere Therapeutic(TVTX.US), With a Forecast Between $68 to $85
- A Quick Look at Today's Ratings for Travere Therapeutic(TVTX.US), With a Forecast Between $62 to $85
- Piper Sandler Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Raises Target Price to $68 正面
- Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Maze Therapeutics, Inc. (MAZE) and Immunome (IMNM)
- CCORF Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Maintains Target Price $70
- Evercore Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Raises Target Price to $78 正面
- Stifel Maintains Travere Therapeutic(TVTX.US) With Hold Rating, Maintains Target Price $62
- CCORF Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Raises Target Price to $62 正面
- TD Cowen Maintains Travere Therapeutic(TVTX.US) With Buy Rating, Maintains Target Price $60
暂无评论——快来第一个聊聊 TVTX。
登录后参与讨论。